References
Laing, A.B.G.; Waters, M.F.R. and Rees, R.H.W.: Four-weekly ‘pulse’ therapy with rifampicin in sulphone-resistant lepro-matous leprosy — interim report. International Journal of Leprosy 46: 684 (1978).
Lim, K.J.: Country information (Malaysia); in Final Report. Regional Working Group on Drug Policy and Operational Research in the Leprosy Programme, Manila, Philippines, 16–18 February 1981 (WHO WPRO, Manila, Philippines, June 1981).
Meade, T.W. et al.: The epidemiology of sulphone-resistant leprosy. International Journal of Leprosy 41: 684 (1973).
Pearson, J.M.H.: The problem of dapsone-resistant leprosy. International Journal of Leprosy 49: 417–420 (1981).
Pearson, J.M.H.; Haile, G.S.; Barnetson, R.S. and Rees, R.J.: Dapsone resistant leprosy in Ethiopia. Leprosy Review 50: 183–199 (1979).
Pettit, J.H.S. and Rees, R.J.W.: Sulphone resistance in leprosy. An experimental and clinical study. Lancet 2: 673–674 (1964).
Pettit, J.H.S.; Rees, R.J.W. and Ridley, D.S.: Studies on sulphone resistance in leprosy. I. Detection of cases. International Journal of Leprosy 34: 375–390 (1966).
Warndorff, J.; Bourland, J. and Pattyn, S.R.: Follow-up on short course two months rifampicin treatment of paucibacillary leprosy. Leprosy Review 53: 9–17 (1982).
WHO Expert Committee on Leprosy, Fifth Report. WHO Technical Report Series No. 607 (Geneva, 1977).
WHO Study Group Report. WHO Technical Report Series No. 675 (Geneva, 1982).
Yawalker, S.J.; McDougall, A.C.; Languillon, J.; Ghosh, S.; Hajra, S.K.; Opromolla, D.V.A. and Tonello, C.J.S.: Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosy. Lancet 1: 1199–1202 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waters, M.F.R. New Approaches to Chemotherapy for Leprosy. Drugs 26, 465–467 (1983). https://doi.org/10.2165/00003495-198326060-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198326060-00001